Redoing work to ease US Food and Drug Administration (FDA) fears about data integrity cost the CRO (contract research organisation) $890,000 from March 26 to April 30 and contributed to it posting a net loss.The net loss before reorganisation expenses totalled $2.7m but costs, mainly professional fees, tied to the ongoing bankruptcy case added a further $360,000 to outgoings at the US-based CRO in